1
|
Guttman Z, Mandelkern M, Ghahremani DG, Kohno M, Dean AC, London ED. Decomposing risky decision-making in methamphetamine use disorder: Behavioral updating and D2 dopamine receptors. Drug Alcohol Depend 2023; 246:109860. [PMID: 37004462 PMCID: PMC10814877 DOI: 10.1016/j.drugalcdep.2023.109860] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/21/2022] [Revised: 03/17/2023] [Accepted: 03/25/2023] [Indexed: 04/04/2023]
Abstract
BACKGROUND Escalating misuse of amphetamine-type stimulants, mainly methamphetamine, has led to a staggering rise in associated overdose deaths and a pressing need to understand the basis of methamphetamine use disorder (MUD). MUD is characterized by disadvantageous decision-making, and people with MUD perform below controls on the Balloon Analogue Risk Task (BART), a laboratory test of decision-making under uncertainty. The BART presents a series of choices with progressively higher stakes-greater risk of loss and greater potential monetary reward. This research aimed to clarify whether impaired behavioral updating contributes to maladaptive performance on the BART. METHODS Two groups (28 drug-abstinent participants with MUD and 16 healthy control participants) were compared on BART performance. Using a computational model, we deconstructed behavior into risk-taking and behavioral updating. A subset of participants (22 MUD, 15 healthy control) underwent [18F]fallypride positron emission tomography scans to measure dopamine D2-type receptor availability (BPND) in the striatum (caudate and accumbens nuclei and putamen) and the globus pallidus. RESULTS Participants with MUD exhibited slower behavioral updating than the healthy controls (p = 0.0004, d=1.77). BPND in all four bilateral volumes of interest were higher in the healthy control group (ps < 0.005, ds < 2.16), and updating rate correlated positively with BPND in the caudate nucleus (p = 0.002), putamen (p = 0.002), and globus pallidus (p = 0.03). CONCLUSIONS The findings indicate that behavioral updating contributes to maladaptive decision-making in MUD and suggest that dysregulation of D2-type receptor signaling in the striatum and globus pallidus contributes to this behavioral deficit.
Collapse
Affiliation(s)
- Zoe Guttman
- Department of Psychiatry and Biobehavioral Sciences and Jane and Terry Semel Institute of Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA 90024, USA
| | - Mark Mandelkern
- Veterans Administration of Greater Los Angeles Health System, Los Angeles, CA 90073, USA; Department of Physics, University of California at Irvine, Irvine, CA 92697, USA
| | - Dara G Ghahremani
- Department of Psychiatry and Biobehavioral Sciences and Jane and Terry Semel Institute of Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA 90024, USA
| | - Milky Kohno
- Department of Psychiatry, Oregon Health & Science University, Oregon Health Sciences University, Portland, OR 97239, USA
| | - Andy C Dean
- Department of Psychiatry and Biobehavioral Sciences and Jane and Terry Semel Institute of Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA 90024, USA
| | - Edythe D London
- Department of Psychiatry and Biobehavioral Sciences and Jane and Terry Semel Institute of Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA 90024, USA; Veterans Administration of Greater Los Angeles Health System, Los Angeles, CA 90073, USA; Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA 90024, USA; Brain Research Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90024, USA.
| |
Collapse
|
2
|
Kikuchi M, Ishihara S, Kohno M. Correction to: Politics of COVID-19 vaccination in Japan: how governing incumbents' representation affected regional rollout variation. BMC Public Health 2023; 23:781. [PMID: 37118786 PMCID: PMC10141814 DOI: 10.1186/s12889-023-15744-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/30/2023] Open
Affiliation(s)
- M Kikuchi
- Department of Political Science, Washington University in St. Louis, Saint Louis, MO, USA.
| | - S Ishihara
- Department of Global Political Economy, Waseda University, Tokyo, Japan
| | - M Kohno
- Faculty of Political Science and Economics, Waseda University, Tokyo, Japan
| |
Collapse
|
3
|
Kikuchi M, Ishihara S, Kohno M. Politics of COVID-19 vaccination in Japan: how governing incumbents' representation affected regional rollout variation. BMC Public Health 2023; 23:515. [PMID: 36932360 PMCID: PMC10021041 DOI: 10.1186/s12889-023-15376-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2022] [Accepted: 03/06/2023] [Indexed: 03/19/2023] Open
Abstract
BACKGROUND Despite initial delay, Japan's COVID-19 vaccination accelerated remarkably from May to September 2021 under the leadership of Prime Minister Yoshihide Suga. His "campaign" for vaccination, however, did not yield uniform results nationwide. METHODS To highlight political determinants for the regional variation, we employ ordinary least squares regression analyses to investigate how the share/presence of incumbent politicians belonging to the governing parties, the Liberal Democratic Party and Komei Party, influenced the varying progress of rollouts across prefectures as well as across cities/towns/villages. The data on the vaccination rate for all 47 prefectures was obtained from Government Chief Information Officer (CIO)'s Portal, Japan (GCPJ) approximately one month prior to the anticipated general election, the national election for the more important House of Representatives of Japan's bicameral parliament (Diet). The data for lower administrative units, though its availability was limited to only three prefectures, was obtained from the respective governments of Kagawa and Ehime and from a local newspaper in Gifu. RESULTS The findings reveal that at both prefectural and sub-prefectural administrative levels, the share/presence of the governing parties' representation in the national parliament had a positive and statistically significant effect on the region's vaccination progress, after controlling for the local proliferation of COVID-19 and demographic characteristics. CONCLUSION Our findings contribute insights into the understudied area of the contemporary COVID-19 health environment, namely how the political dynamics of democracy affect the pattern of vaccine dissemination in Japan. TRIAL REGISTRATION Not applicable.
Collapse
Affiliation(s)
- M Kikuchi
- Department of Political Science, Washington University in St. Louis, MO , Saint Louis, USA.
| | - S Ishihara
- Department of Global Political Economy, Waseda University, Tokyo, Japan
| | - M Kohno
- Faculty of Political Science and Economics, Waseda University, Tokyo, Japan
| |
Collapse
|
4
|
Kida T, Matsuzaki K, Yokota I, Kawase N, Masatoshi K, Inoue H, Yuji K, Kaneshita S, Inoue T, Wada M, Kohno M, Kawahito Y, Iwami T. POS0875 LATENT TRAJECTORY MODELING OF PULMONARY ARTERY PRESSURE IN SYSTEMIC SCLEROSIS: A RETROSPECTIVE COHORT STUDY. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.2192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundSystemic sclerosis (SSc) is an autoimmune disease that is characterized by systemic vasculopathy and fibrosis. Pulmonary hypertension (PH), defined as elevated pulmonary arterial pressure (PAP), is one of the leading causes of death of SSc1. In recent years, various therapies have been developed to target each of the pathogenesis of SSc – autoimmunity, vasculopathy, and fibrosis. Accordingly, treatment strategies based on risk stratification for PH progression are aspired; however, prediction of changes in PAP in diverse patients with SSc has not been established2.ObjectivesTo visualize the patterns of PAP elevation in SSc and to identify the clinical characteristics of each trajectory, by applying latent trajectory modeling for PAP measured repeatedly by echocardiography.MethodsThis was a multicenter, retrospective cohort study conducted at four referral hospitals in Kyoto, Japan. Patients with SSc who visited the study site between April 2008 and March 2021 and had at least three echocardiographic measurements of systolic pulmonary arterial pressure (sPAP) were included in this study. Follow-up concluded in March 2021. A group-based trajectory model3 was applied to the change in sPAP over time, and individual patients were classified into distinct subgroups that followed similar trajectories. The number and shape of the trajectories were estimated based on adequacy, goodness of fit, parsimony, and interpretability of the model. Clinical plausibility was assessed by comparing PH-free survival, i.e., time to either PH or death, for each trajectory. Multinomial logistic regression analysis was performed for baseline clinical characteristics associated with trajectory assignment.ResultsA total of 236 patients with a total of 1097 sPAP measurements were included. We identified five trajectories following the quadratic function as “rapid progression (n=9, 3.8%)”, “early elevation (n=30, 12.7%)”, “mid elevation (n=54, 22.9%)”, “late elevation (n=24, 10.2%)”, and “low stable (n=119, 50.4%)”. Each trajectory, in this order, showed earlier elevation of sPAP and shorter PH-free survival (Figure 1). In the multinomial logistic regression (with the “low stable” as reference), cardiac involvement was associated with the “rapid progression” (adjusted odds ratio [OR] 28.9, 95% confidence interval [CI] 3.21–259.5), diffuse cutaneous SSc was associated with the “early elevation” (OR 4.08, 95% CI 1.27–13.1), anti-centromere antibody positive was associated with the “mid elevation” (OR 4.50, 95% CI 1.11–18.2), and older age of onset was associated with the above three trajectories.ConclusionThe pattern of changes in pulmonary artery pressure over time in SSc can be classified into five distinct trajectories. Each trajectory differed in baseline clinical characteristics and outcomes.References[1]Pokeerbux MR, et al. Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature. Arthritis Res Ther. 2019;21(1):86.[2]Denton CP, et al. Systemic sclerosis. Lancet. 2017;390(10103):1685-1699.[3]Nagin DS, et al. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109-38.Disclosure of InterestsNone declared
Collapse
|
5
|
Watanabe T, Kawashima M, Kohno M, Yeung J, Martinu T, Aversa M, Donahoe L, Pierre A, de Perrot M, Yasufuku K, Waddell T, Keshavjee S, Cypel M. First North American Experience with Lung Transplantation from Donation After Medical Assistance in Dying. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.1620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
6
|
Kohno M, Dennis LE, McCready H, Hoffman WF. Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment. Mol Psychiatry 2022; 27:220-229. [PMID: 34117366 PMCID: PMC8664889 DOI: 10.1038/s41380-021-01180-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/16/2021] [Revised: 05/13/2021] [Accepted: 05/26/2021] [Indexed: 12/14/2022]
Abstract
Dopamine system deficiencies and associated behavioral phenotypes may be a critical barrier to success in treating stimulant use disorders. Similarities in dopamine dysfunction between cocaine and methamphetamine use disorder but also key differences may impact treatment efficacy and outcome. This review will first compare the epidemiology of cocaine and methamphetamine use disorder. A detailed account of the pharmacokinetic and pharmacodynamic properties associated with each drug will then be discussed, with an emphasis on effects on the dopamine system and associated signaling pathways. Lastly, treatment results from pharmacological clinical trials will be summarized along with a more comprehensive review of the involvement of the trace amine-associated receptor on dopamine signaling dysfunction among stimulants and its potential as a therapeutic target.
Collapse
Affiliation(s)
- Milky Kohno
- Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA. .,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA. .,Research and Development Service, Veterans Affairs Portland Health Care System, Portland, OR, USA. .,Methamphetamine Abuse Research Center, Oregon Health & Science University and Veterans Affairs Portland Health Care System, Portland, OR, USA.
| | - Laura E. Dennis
- Department of Psychiatry, Oregon Health & Science University, Portland, Oregon, USA,Research & Development Service, Veterans Affairs Portland Health Care System, Portland, Oregon, USA
| | - Holly McCready
- Department of Psychiatry, Oregon Health & Science University, Portland, Oregon, USA,Research & Development Service, Veterans Affairs Portland Health Care System, Portland, Oregon, USA
| | - William F. Hoffman
- Department of Psychiatry, Oregon Health & Science University, Portland, Oregon, USA,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon, USA,Research & Development Service, Veterans Affairs Portland Health Care System, Portland, Oregon, USA,Mental Health Division, Veterans Affairs Portland Health Care System, Portland, Oregon, USA,Methamphetamine Abuse Research Center, Oregon Health & Science University and Veterans Affairs Portland Health Care System, Portland, Oregon, USA
| |
Collapse
|
7
|
Huckans M, Boyd S, Moncrief G, Hantke N, Winters B, Shirley K, Sano E, McCready H, Dennis L, Kohno M, Hoffman W, Loftis JM. Cognition during active methamphetamine use versus remission. J Clin Exp Neuropsychol 2021; 43:599-610. [PMID: 34612792 DOI: 10.1080/13803395.2021.1976734] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
OBJECTIVE To evaluate whether cognitive performance in adults with active methamphetamine use (MA-ACT) differs from cognitive performance in adults in remission from MA use disorder (MA-REM) and adults without a history of substance use disorder (CTLs). METHOD MA-ACT (n = 36), MA-REM (n = 48), and CTLs (n = 62) completed the Neuropsychological Assessment Battery (NAB). RESULTS The MA-ACT group did not perform significantly worse than CTLs on any NAB Index. The MA-REM group performed significantly (p < 0.050) worse than CTLs on the NAB Memory Index. The MA-ACT group performed significantly better than CTLs and the MA-REM group on the Executive Functions Index. CONCLUSIONS Some cognitive deficits are apparent during remission from MA use, but not during active use; this may result in clinical challenges for adults attempting to maintain recovery and continue with treatment.
Collapse
Affiliation(s)
- Marilyn Huckans
- Research & Development Service, Veterans Affairs Portland Health Care System, Portland, OR, USA.,Mental Health and Clinical Neurosciences Division, Veterans Affairs Portland Health Care System, Portland, Or, USA.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.,Methamphetamine Research Center, Oregon Health & Science University, Portland, Or, USA
| | - Stephen Boyd
- Department of Anesthesia and Perioperative Medicine, Oregon Health & Science University, Portland, Or, USA
| | - Grant Moncrief
- Research & Development Service, Veterans Affairs Portland Health Care System, Portland, OR, USA.,Mental Health and Clinical Neurosciences Division, Veterans Affairs Portland Health Care System, Portland, Or, USA.,Pacific University, School of Graduate Psychology, Hillsboro, OR, USA.,Department of Psychiatry, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
| | - Nathan Hantke
- Research & Development Service, Veterans Affairs Portland Health Care System, Portland, OR, USA.,Mental Health and Clinical Neurosciences Division, Veterans Affairs Portland Health Care System, Portland, Or, USA.,Department of Neurology, Oregon Health & Science University, Portland, OR, USA
| | - Bethany Winters
- Research & Development Service, Veterans Affairs Portland Health Care System, Portland, OR, USA.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.,Methamphetamine Research Center, Oregon Health & Science University, Portland, Or, USA
| | - Kate Shirley
- Research & Development Service, Veterans Affairs Portland Health Care System, Portland, OR, USA
| | - Emily Sano
- Research & Development Service, Veterans Affairs Portland Health Care System, Portland, OR, USA
| | - Holly McCready
- Research & Development Service, Veterans Affairs Portland Health Care System, Portland, OR, USA.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.,Methamphetamine Research Center, Oregon Health & Science University, Portland, Or, USA.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Or, USA
| | - Laura Dennis
- Research & Development Service, Veterans Affairs Portland Health Care System, Portland, OR, USA.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.,Methamphetamine Research Center, Oregon Health & Science University, Portland, Or, USA.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Or, USA
| | - Milky Kohno
- Research & Development Service, Veterans Affairs Portland Health Care System, Portland, OR, USA.,Methamphetamine Research Center, Oregon Health & Science University, Portland, Or, USA.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Or, USA
| | - William Hoffman
- Research & Development Service, Veterans Affairs Portland Health Care System, Portland, OR, USA.,Mental Health and Clinical Neurosciences Division, Veterans Affairs Portland Health Care System, Portland, Or, USA.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.,Methamphetamine Research Center, Oregon Health & Science University, Portland, Or, USA.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Or, USA
| | - Jennifer M Loftis
- Research & Development Service, Veterans Affairs Portland Health Care System, Portland, OR, USA.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.,Methamphetamine Research Center, Oregon Health & Science University, Portland, Or, USA
| |
Collapse
|
8
|
Burnette EM, Grodin EN, Ghahremani DG, Galván A, Kohno M, Ray LA, London ED. Diminished cortical response to risk and loss during risky decision making in alcohol use disorder. Drug Alcohol Depend 2021; 218:108391. [PMID: 33153830 PMCID: PMC7750289 DOI: 10.1016/j.drugalcdep.2020.108391] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2020] [Revised: 10/23/2020] [Accepted: 10/26/2020] [Indexed: 10/23/2022]
Abstract
BACKGROUND Risky decision-making is an important facet of addiction. Individuals with alcohol dependence show abnormalities in gambling and other risk-taking tasks. In one such measure, the Balloon Analogue Risk Task (BART), participants sequentially choose to pump a virtual balloon to increase potential reward while the risk of explosion increases, or to cash-out and take earnings. In a prior study, alcohol-dependent participants differed from controls in brain activation during decision-making on the BART, but the relationship between risk/reward magnitude and brain activation was not studied, nor were participants compared to controls. Here we compared the degree to which risk and magnitude of reward influenced brain activation in alcohol-dependent participants vs. controls during decision-making on the BART. METHODS Thirty-two participants (16 alcohol-dependent, 16 control; 5 females/group) performed the BART during fMRI. A parametric analysis tested for a relationship between risk/reward magnitude and activation in rDLPFC and bilateral striatum regions of interest when participants chose to take risk or to cash out. An exploratory whole-brain voxel-wise analysis of mean activation during pumping, cash-out, and explosion events was also conducted. RESULTS Compared with controls, alcohol-dependent participants displayed less modulation of activation in the rDLPFC when taking risk. Exploratory analyses found that alcohol-dependent participants showed less activation than controls during explosions in a cluster including the insula. No differences were seen in striatal activation. CONCLUSIONS Insensitivity of the rDLPFC to risk and of the insula to loss may contribute to decision-making deficits in alcohol dependence.
Collapse
Affiliation(s)
- Elizabeth M. Burnette
- Department of Psychology, University of California, Los Angeles, CA,Neuroscience Interdepartmental Program, University of California, Los Angeles, CA
| | - Erica N. Grodin
- Department of Psychology, University of California, Los Angeles, CA,Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Los Angeles, CA
| | - Dara G. Ghahremani
- Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Los Angeles, CA
| | - Adriana Galván
- Department of Psychology, University of California, Los Angeles, CA,Neuroscience Interdepartmental Program, University of California, Los Angeles, CA,Brain Research Institute, University of California, Los Angeles, CA
| | - Milky Kohno
- Department of Psychiatry, Oregon Health and Sciences University, Portland, OR
| | - Lara A. Ray
- Department of Psychology, University of California, Los Angeles, CA,Neuroscience Interdepartmental Program, University of California, Los Angeles, CA,Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Los Angeles, CA,Brain Research Institute, University of California, Los Angeles, CA
| | - Edythe D. London
- Neuroscience Interdepartmental Program, University of California, Los Angeles, CA,Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Los Angeles, CA,Brain Research Institute, University of California, Los Angeles, CA,Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA
| |
Collapse
|
9
|
Dennis LE, Kohno M, McCready HD, Schwartz DL, Schwartz B, Lahna D, Nagel BJ, Mitchell SH, Hoffman WF. Correction to: Neural correlates of reward magnitude and delay during a probabilistic delay discounting task in alcohol use disorder. Psychopharmacology (Berl) 2020; 237:279. [PMID: 31863122 DOI: 10.1007/s00213-019-05440-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
After publication of this paper, the authors determined an error in the funding information section CX17008-CDA2 should be CX001790 (MK).
Collapse
Affiliation(s)
- Laura E Dennis
- Mental Health Division P35C, Veterans Affairs Portland Health Care System, 3710 SW US Veterans Hospital Rd, Portland, OR, 97239, USA.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA
| | - Milky Kohno
- Mental Health Division P35C, Veterans Affairs Portland Health Care System, 3710 SW US Veterans Hospital Rd, Portland, OR, 97239, USA. .,Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA. .,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA.
| | - Holly D McCready
- Mental Health Division P35C, Veterans Affairs Portland Health Care System, 3710 SW US Veterans Hospital Rd, Portland, OR, 97239, USA.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA
| | - Daniel L Schwartz
- Neurology and Advanced Imaging Research Center, Oregon Health & Science University, Portland, OR, USA
| | - Britta Schwartz
- Mental Health Division P35C, Veterans Affairs Portland Health Care System, 3710 SW US Veterans Hospital Rd, Portland, OR, 97239, USA.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA
| | - David Lahna
- Neurology and Advanced Imaging Research Center, Oregon Health & Science University, Portland, OR, USA
| | - Bonnie J Nagel
- Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA
| | - Suzanne H Mitchell
- Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA.,Oregon Institute for Occupational Health Sciences, Oregon Health & Science University, Portland, OR, USA
| | - William F Hoffman
- Mental Health Division P35C, Veterans Affairs Portland Health Care System, 3710 SW US Veterans Hospital Rd, Portland, OR, 97239, USA.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA.,Methamphetamine Abuse Research Center (MARC), Oregon Health & Science University and Veterans Affairs Portland Health Care System, Portland, OR, USA
| |
Collapse
|
10
|
Hoffman WF, Jacobs MB, Dennis LE, McCready HD, Hickok AW, Smith SB, Kohno M. Psychopathy and Corticostriatal Connectivity: The Link to Criminal Behavior in Methamphetamine Dependence. Front Psychiatry 2020; 11:90. [PMID: 32180738 PMCID: PMC7059248 DOI: 10.3389/fpsyt.2020.00090] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/29/2019] [Accepted: 02/03/2020] [Indexed: 01/17/2023] Open
Abstract
Methamphetamine use and psychopathy are associated with criminal behavior; however, it is unclear how methamphetamine use and psychopathy interact to promote violent, economic and drug offenses. Abnormalities in corticostriatal functional connectivity are exhibited in both psychopathic and methamphetamine dependent individuals, which may contribute to criminal behavior through maladaptive and impulsive decision-making processes. This study shows that psychopathic traits contribute to weaker corticostriatal connectivity in methamphetamine dependence and contributes to an increase in criminal behavior. As the propensity to engage in criminal activity is dependent on a number of factors, a hierarchical regression identifies the contribution of the impulsive antisocial domain of psychopathy, anxiety, years of methamphetamine use and corticostriatal connectivity on different types of criminal offenses. Methamphetamine use and psychopathic traits reduce treatment responsiveness and increase the likelihood of recidivism, and it is therefore important to understand the factors underlying the propensity to engage in criminal behavior.
Collapse
Affiliation(s)
- William F Hoffman
- Mental Health Division P35C, Veterans Affairs Portland Health Care System, Portland, OR, United States.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, United States.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States.,Methamphetamine Abuse Research Center (MARC), Oregon Health & Science University and Veterans Affairs Portland Health Care System, Portland, OR, United States
| | - Merel B Jacobs
- Mental Health Division P35C, Veterans Affairs Portland Health Care System, Portland, OR, United States.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, United States
| | - Laura E Dennis
- Mental Health Division P35C, Veterans Affairs Portland Health Care System, Portland, OR, United States.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, United States
| | - Holly D McCready
- Mental Health Division P35C, Veterans Affairs Portland Health Care System, Portland, OR, United States.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, United States
| | - Alex W Hickok
- Center of Innovation to Improve Veteran Involvement in their Care, VA Portland VA Healthcare System, Portland, OR, United States
| | - Sheehan B Smith
- Mental Health Division P35C, Veterans Affairs Portland Health Care System, Portland, OR, United States.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, United States
| | - Milky Kohno
- Mental Health Division P35C, Veterans Affairs Portland Health Care System, Portland, OR, United States.,Department of Psychiatry, Oregon Health & Science University, Portland, OR, United States.,Methamphetamine Abuse Research Center (MARC), Oregon Health & Science University and Veterans Affairs Portland Health Care System, Portland, OR, United States
| |
Collapse
|
11
|
Pilhatsch M, Pooseh S, Junke A, Kohno M, Petzold J, Sauer C, Smolka MN. Probabilistic Reversal Learning Deficits in Patients With Methamphetamine Use Disorder-A Longitudinal Pilot Study. Front Psychiatry 2020; 11:588768. [PMID: 33362606 PMCID: PMC7755887 DOI: 10.3389/fpsyt.2020.588768] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/29/2020] [Accepted: 10/14/2020] [Indexed: 01/21/2023] Open
Abstract
Methamphetamine use disorder (MUD) is increasing worldwide and commonly associated with learning deficits. Little is known the about underlying trajectories, i.e., how the affected higher-order cognitive functions develop over time and with respect to abstinence and relapse. A probabilistic reversal learning (PRL) paradigm was implemented to uncover the microstructure of impulsive choice and maladaptive learning strategies in 23 patients with MUD in comparison with 24 controls. Baseline data revealed fewer optimal choices and a pattern of altered learning behavior from negative and positive feedback in patients suggesting impairments in flexibly-adapting behavior to changes of reward contingencies. Integrating longitudinal data from a follow-up assessment after 3 months of specific treatment revealed a group-by-time interaction indicating a normalization of these cognitive impairments in patients with MUD. In summary, our study demonstrates behavioral correlates of maladaptive decision-making processes in patients with MUD, which may recover after 3 months of MUD-specific therapy paving the way for further learning-based interventions. Limited by a small sample size, the results of this pilot study warrant replication in larger populations.
Collapse
Affiliation(s)
- Maximilian Pilhatsch
- Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany.,Department of Psychiatry and Psychotherapy, Elblandklinikum Radebeul, Radebeul, Germany
| | - Shakoor Pooseh
- Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany.,Freiburg Center for Data Analysis and Modeling, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany
| | - Alexandra Junke
- Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany
| | - Milky Kohno
- Department of Psychiatry, Oregon Health and Science University, Portland, OR, United States.,Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.,Research and Development Service, Veterans Affairs Portland Health Care System, Portland, OR, United States.,Methamphetamine Abuse Research Center, Oregon Health and Science University and Veterans Affairs Portland Health Care System, Portland, OR, United States
| | - Johannes Petzold
- Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany
| | - Cathrin Sauer
- Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany
| | - Michael N Smolka
- Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany
| |
Collapse
|
12
|
Kohno M, Beste C, Pilhatsch M. Editorial: The Global Methamphetamine Problem: Approaches to Elucidate the Neurobiology, Epidemiology, and Therapeutic Effectiveness. Front Psychiatry 2020; 11:850. [PMID: 32973588 PMCID: PMC7468440 DOI: 10.3389/fpsyt.2020.00850] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2020] [Accepted: 08/04/2020] [Indexed: 11/30/2022] Open
Affiliation(s)
- Milky Kohno
- Department of Psychiatry, Oregon Health and Science University, Portland, OR, United States.,Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.,Research and Development Service, Veterans Affairs Portland Health Care System, Portland, OR, United States.,Methamphetamine Abuse Research Center, Oregon Health and Science University and Veterans Affairs Portland Health Care System, Portland, OR, United States
| | - Christian Beste
- Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany
| | - Maximilian Pilhatsch
- Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany.,Department of Psychiatry and Psychotherapy, Elblandklinikum Radebeul, Radebeul, Germany
| |
Collapse
|
13
|
Kohno M, Link J, Dennis LE, McCready H, Huckans M, Hoffman WF, Loftis JM. Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies. Pharmacol Biochem Behav 2019; 179:34-42. [PMID: 30695700 DOI: 10.1016/j.pbb.2019.01.007] [Citation(s) in RCA: 92] [Impact Index Per Article: 18.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/06/2018] [Revised: 01/22/2019] [Accepted: 01/25/2019] [Indexed: 12/29/2022]
Abstract
Addiction is a worldwide public health problem and this article reviews scientific advances in identifying the role of neuroinflammation in the genesis, maintenance, and treatment of substance use disorders. With an emphasis on neuroimaging techniques, this review examines human studies of addiction using positron emission tomography to identify binding of translocator protein (TSPO), which is upregulated in reactive glial cells and activated microglia during pathological states. High TSPO levels have been shown in methamphetamine use but exhibits variable patterns in cocaine use. Alcohol and nicotine use, however, are associated with lower TSPO levels. We discuss how mechanistic differences at the neurotransmitter and circuit level in the neural effects of these agents and subsequent immune response may explain these observations. Finally, we review the potential of anti-inflammatory drugs, including ibudilast, minocycline, and pioglitazone, to ameliorate the behavioral and cognitive consequences of addiction.
Collapse
Affiliation(s)
- Milky Kohno
- Research & Development Service, Veterans Affairs Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA; Department of Psychiatry, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, USA; Methamphetamine Abuse Research Center, Oregon Health & Science University and Veterans Affairs Portland Health Care System, Portland, OR, USA
| | - Jeanne Link
- Center for Radiochemistry Research, Knight Cardiovascular Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, USA
| | - Laura E Dennis
- Research & Development Service, Veterans Affairs Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA; Methamphetamine Abuse Research Center, Oregon Health & Science University and Veterans Affairs Portland Health Care System, Portland, OR, USA
| | - Holly McCready
- Research & Development Service, Veterans Affairs Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA; Methamphetamine Abuse Research Center, Oregon Health & Science University and Veterans Affairs Portland Health Care System, Portland, OR, USA
| | - Marilyn Huckans
- Department of Psychiatry, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, USA; Mental Health and Clinical Neurosciences Division, Veterans Affairs Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA; Methamphetamine Abuse Research Center, Oregon Health & Science University and Veterans Affairs Portland Health Care System, Portland, OR, USA
| | - William F Hoffman
- Research & Development Service, Veterans Affairs Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA; Department of Psychiatry, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, USA; Department of Behavioral Neuroscience, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, USA; Mental Health and Clinical Neurosciences Division, Veterans Affairs Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA; Methamphetamine Abuse Research Center, Oregon Health & Science University and Veterans Affairs Portland Health Care System, Portland, OR, USA
| | - Jennifer M Loftis
- Research & Development Service, Veterans Affairs Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, USA; Department of Psychiatry, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, USA; Methamphetamine Abuse Research Center, Oregon Health & Science University and Veterans Affairs Portland Health Care System, Portland, OR, USA.
| |
Collapse
|
14
|
Kohno M, Morales AM, Dennis LE, McCready H, Hoffman WF, Korthuis PT. Effects of Naltrexone on Large-Scale Network Interactions in Methamphetamine Use Disorder. Front Psychiatry 2019; 10:603. [PMID: 31551824 PMCID: PMC6735261 DOI: 10.3389/fpsyt.2019.00603] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2019] [Accepted: 07/30/2019] [Indexed: 01/24/2023] Open
Abstract
Naltrexone attenuates craving, and the subjective effects of methamphetamine and extended-release naltrexone (XR-NTX) reduces functional connectivity between regions of the striatum and limbic cortex. Naltrexone modulates neural activity at dopaminergic synapses; however, it is unclear whether naltrexone has an effect on large-scale brain networks. Functional networks interact to coordinate behavior, and as substance-use disorders are associated with an imbalance between reward and cognitive control networks, treatment approaches that target interactive brain systems underlying addiction may be a useful adjunct for behavioral therapies. The objective of this study was to examine the effect of XR-NTX on large-scale brain networks and to determine whether changes in network relationships attenuate drug use, craving, and addiction severity. Thirty-nine participants in or seeking treatment for methamphetamine-use disorder were enrolled in a clinical trial of XR-NTX between May 2013 and March 2015 (Clinicaltrials.gov NCT01822132). Functional magnetic resonance imaging (fMRI) and questionnaires were conducted before and after double-blinded randomization to a 4-week injection of XR-NTX or placebo. In the XR-NTX group, methamphetamine use was reduced along with a decrease in the coupling between executive control (ECN) and default mode (DMN) networks. As decoupling of ECN and DMN networks was associated with change in the severity of dependence, the results suggest that XR-NTX may modulate and enhance ECN attentional resources and suppress DMN self-referential and emotional processing. This study identifies the effect of naltrexone on changes in the intrinsic functional coupling of large-scale brain networks and provides a more systematic understanding of how large-scale networks interact to promote behavioral change in methamphetamine-use disorder.
Collapse
Affiliation(s)
- Milky Kohno
- Department of Psychiatry, Oregon Health and Science University, Portland, OR, United States.,Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.,Research and Development Service, Veterans Affairs Portland Health Care System, Portland, OR, United States.,Methamphetamine Abuse Research Center, Oregon Health and Science University and Veterans Affairs Portland Health Care System, Portland, OR, United States
| | - Angelica M Morales
- Department of Psychiatry, Oregon Health and Science University, Portland, OR, United States.,Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States
| | - Laura E Dennis
- Department of Psychiatry, Oregon Health and Science University, Portland, OR, United States.,Research and Development Service, Veterans Affairs Portland Health Care System, Portland, OR, United States
| | - Holly McCready
- Department of Psychiatry, Oregon Health and Science University, Portland, OR, United States.,Research and Development Service, Veterans Affairs Portland Health Care System, Portland, OR, United States
| | - William F Hoffman
- Department of Psychiatry, Oregon Health and Science University, Portland, OR, United States.,Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.,Research and Development Service, Veterans Affairs Portland Health Care System, Portland, OR, United States.,Methamphetamine Abuse Research Center, Oregon Health and Science University and Veterans Affairs Portland Health Care System, Portland, OR, United States.,Mental Health Division, Veterans Affairs Portland Health Care System, Portland, OR, United States
| | - P Todd Korthuis
- Section of Addiction Medicine, Oregon Health and Science University, Portland, OR, United States
| |
Collapse
|
15
|
McCready H, Kohno M, Kolessar M, Dennis L, Kriz D, Luber H, Anderson R, Chang M, Sasaki A, Flora K, Vandenbark A, Mitchell SH, Loftis JM, Hoffman WF, Huckans M. Functional MRI and delay discounting in patients infected with hepatitis C. J Neurovirol 2018; 24:738-751. [PMID: 30298201 PMCID: PMC6279508 DOI: 10.1007/s13365-018-0670-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2017] [Revised: 04/23/2018] [Accepted: 08/15/2018] [Indexed: 02/06/2023]
Abstract
Hepatitis C virus-infected (HCV+) adults evidence increased rates of psychiatric and cognitive difficulties. This is the first study to use functional magnetic resonance imaging (fMRI) to examine brain activation in untreated HCV+ adults. To determine whether, relative to non-infected controls (CTLs), HCV+ adults exhibit differences in brain activation during a delay discounting task (DDT), a measure of one's tendency to choose smaller immediate rewards over larger delayed rewards-one aspect of impulsivity. Twenty adults with HCV and 26 CTLs completed an fMRI protocol during the DDT. Mixed effects regression analyses of hard versus easy trials of the DDT showed that, compared with CTLs, the HCV+ group exhibited less activation in the left lateral occipital gyrus, precuneus, and superior frontal gyrus. There were also significant interactive effects for hard-easy contrasts in the bilateral medial frontal gyrus, left insula, left precuneus, left inferior parietal lobule, and right temporal occipital gyrus; the CTL group evidenced a positive relationship between impulsivity and activation, while the HCV+ group exhibited a negative relationship. Within the HCV+ group, those with high viral load chose immediate rewards more often than those with low viral load, regardless of choice difficulty; those with low viral load chose immediate rewards more often on hard choices relative to easy choices. Results show that HCV+ patients exhibit greater impulsive behavior when presented with difficult choices, and impulsivity is negatively related to activation in regions important for cognitive control. Thus, interventions that decrease impulsive choice may be warranted with some HCV+ patients.
Collapse
Affiliation(s)
- Holly McCready
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
- Department of Behavioral Neuroscience, School of Medicine, Oregon Health and Science University, Portland, OR, USA
- Department of Psychiatry, School of Medicine, Oregon Health and Science University, Portland, OR, USA
| | - Milky Kohno
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
- Department of Behavioral Neuroscience, School of Medicine, Oregon Health and Science University, Portland, OR, USA
- Department of Psychiatry, School of Medicine, Oregon Health and Science University, Portland, OR, USA
| | - Michael Kolessar
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
- Department of PM&R and Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - Laura Dennis
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
- Department of Behavioral Neuroscience, School of Medicine, Oregon Health and Science University, Portland, OR, USA
- Department of Psychiatry, School of Medicine, Oregon Health and Science University, Portland, OR, USA
| | - Daniel Kriz
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
| | - Hannah Luber
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
| | - Renee Anderson
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
| | - Michael Chang
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
- The Northwest Hepatitis C Resource Center, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
| | - Anna Sasaki
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
- The Northwest Hepatitis C Resource Center, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
| | - Kenneth Flora
- Department of Gastroenterology, The Oregon Clinic, Portland, OR, USA
| | - Arthur Vandenbark
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
- Department of Neurology, School of Medicine, Oregon Health and Science University, Portland, OR, USA
- Department of Molecular Microbiology and Immunology, School of Medicine, Oregon Health and Science University, Portland, OR, USA
| | - Suzanne H Mitchell
- Department of Behavioral Neuroscience, School of Medicine, Oregon Health and Science University, Portland, OR, USA
- Department of Psychiatry, School of Medicine, Oregon Health and Science University, Portland, OR, USA
- Oregon Institute of Occupational Health Sciences, School of Medicine, Oregon Health and Science University, Portland, OR, USA
| | - Jennifer M Loftis
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
- Department of Psychiatry, School of Medicine, Oregon Health and Science University, Portland, OR, USA
- The Northwest Hepatitis C Resource Center, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
| | - William F Hoffman
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
- Department of Behavioral Neuroscience, School of Medicine, Oregon Health and Science University, Portland, OR, USA
- Department of Psychiatry, School of Medicine, Oregon Health and Science University, Portland, OR, USA
- Behavioral Health & Clinical Neurosciences Division, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA
| | - Marilyn Huckans
- Research and Development, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA.
- Department of Psychiatry, School of Medicine, Oregon Health and Science University, Portland, OR, USA.
- The Northwest Hepatitis C Resource Center, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA.
- Behavioral Health & Clinical Neurosciences Division, VA Portland Health Care System, 3710 SW US Veteran's Hospital Road, Portland, OR, 97239, USA.
| |
Collapse
|
16
|
Wu L, Chan M, Mckee T, Butt S, Cabanero M, Green B, Duong B, Yun Z, Kohno M, Murakami J, Zhao Y, Kelley S, De Perrot M. P2.06-38 Mesothelioma Stem Cells May Be the Critical Factor of Treatment Failure. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
17
|
Hama Y, Uematsu M, Ichikura T, Tamura E, Aida S, Kohno M, Kusano S. A Case of Primary Small Cell Carcinoma of the Cervical Esophagus with Long-term Survival following Concurrent Chemoradiotherapy: Case Report and Review of the Literature. Tumori 2018; 85:284-7. [PMID: 10587033 DOI: 10.1177/030089169908500414] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The authors describe a case of small cell carcinoma of the esophagus that was treated by concurrent chemoradiotherapy. Both the esophageal tumor and the regional lymph node metastases disappeared after this treatment. The patient is alive and disease free after more than five years. Primary small cell carcinoma of the esophagus is a rare and aggressive neoplasm with a very poor prognosis, and the treatment modality is controversial. This case illustrates the possibility of treating this tumor type with concurrent chemoradiotherapy.
Collapse
Affiliation(s)
- Y Hama
- Department of Radiology, National Defense Medical College, Tokorozawa, Japan
| | | | | | | | | | | | | |
Collapse
|
18
|
Kohno M, Wu L, De La Maza L, Yun Z, Chan M, Yao Y, Zhao Y, De Perrot M. OA 02.06 Radioimmunotherapy Combining CTLA-4 Blockade or Low-Dose Cyclophosphamide with Local Radiation in Murine Malignant Mesothelioma. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
19
|
Hashimoto R, Kohno M, Tsuboi T, Matsuzaki T, Oiwa K, Hamamoto A, Nakagawa T, Masuda R, Iwazaki M. P-136ANALYSIS OF CYTOKINES IN EPITHELIAL LINING FLUID SERIALLY COLLECTED USING BRONCHOSCOPIC MICROSAMPLING TECHNIQUE IN A CANINE LUNG TRANSPLANT MODEL. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
20
|
Hashimoto R, Kohno M, Watanabe M, Horinouchi H, Sakai H, Kobayashi K, Iwazaki M. P-091IMMEDIATE EFFECTS OF SYSTEMIC ADMINISTRATION OF HIGH-OXYGEN-AFFINITY HAEMOGLOBIN VESICLES IN A RAT PNEUMONECTOMY MODEL. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
21
|
Ishiguchi H, Kobayashi S, Kohno M, Nanno T, Myoren T, Oda S, Tateishi H, Mochizuki M, Oda T, Yamada J, Okamura T, Yano M. P5408Urinary 8-hydroxy-2-deoxyguanosine as a novel myocardial oxidative stress marker for sustained ventricular tachycardia in patients with active cardiac sarcoidosis. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p5408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
22
|
Nisa H, Hirata A, Kohno M, Kiyohara C, Ohnaka K. HIGH-SENSITIVITY C-REACTIVE PROTEIN AND RISKS OF ALL-CAUSE AND CAUSE-SPECIFIC MORTALITY IN JAPAN. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.2890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- H. Nisa
- Department of Public Health Faculty of Medicine and Health Sciences, Syarif Hidayatullah State Islamic University Jakarta, Tangerang Selatan, Banten, Indonesia,
| | - A. Hirata
- Department of Geriatric Medicine Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan,
| | - M. Kohno
- Department of Geriatric Medicine Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan,
| | - C. Kiyohara
- Department of Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - K. Ohnaka
- Department of Geriatric Medicine Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan,
| |
Collapse
|
23
|
Kohno M, Morales AM, Guttman Z, London ED. A neural network that links brain function, white-matter structure and risky behavior. Neuroimage 2017; 149:15-22. [PMID: 28131889 DOI: 10.1016/j.neuroimage.2017.01.058] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2016] [Revised: 01/03/2017] [Accepted: 01/24/2017] [Indexed: 10/20/2022] Open
Abstract
The ability to evaluate the balance between risk and reward and to adjust behavior accordingly is fundamental to adaptive decision-making. Although brain-imaging studies consistently have shown involvement of the dorsolateral prefrontal cortex, anterior insula and striatum during risky decision-making, activation in a neural network formed by these regions has not been linked to structural connectivity. Therefore, in this study, white-matter connectivity was measured with diffusion-weighted imaging in 40 healthy research participants who performed the Balloon Analogue Risk Task, a test of risky decision-making, during fMRI. Fractional anisotropy within a network that includes white-matter pathways connecting four regions (the prefrontal cortex, insula and midbrain to the striatum) was positively correlated with the number of risky choices and total amount earned on the task, and with the parametric modulation of activation in regions within the network to the level of risk during choice selection. Furthermore, analysis using a mixed model demonstrated how relationships of the parametric modulation of activation in each of the four aforementioned regions are related to risk probabilities, and how previous trial outcomes and task progression influence the choice to take risk. The present findings provide the first direct evidence that white-matter integrity is linked to function within previously identified components of a network that is activated during risky decision-making, and demonstrate that the integrity of white-matter tracts is critical in consolidating and processing signals between cortical and striatal circuits during the decision-making process.
Collapse
Affiliation(s)
- Milky Kohno
- Dept. of Psychiatry & Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA 90095, USA
| | - Angelica M Morales
- Dept. of Psychiatry & Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA 90095, USA
| | - Zoe Guttman
- Neuroscience Interdepartmental Program, University of California Los Angeles, Los Angeles, CA 90095, USA
| | - Edythe D London
- Dept. of Psychiatry & Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA 90095, USA; Neuroscience Interdepartmental Program, University of California Los Angeles, Los Angeles, CA 90095, USA; Dept. of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, CA 90095, USA; Brain Research Institute, University of California Los Angeles, Los Angeles, CA 90095, USA.
| |
Collapse
|
24
|
Kohno M, Dennis LE, McCready H, Hoffman WF. Executive Control and Striatal Resting-State Network Interact with Risk Factors to Influence Treatment Outcomes in Alcohol-Use Disorder. Front Psychiatry 2017; 8:182. [PMID: 28993741 PMCID: PMC5622290 DOI: 10.3389/fpsyt.2017.00182] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/24/2017] [Accepted: 09/11/2017] [Indexed: 12/20/2022] Open
Abstract
Alterations within mesocorticolimbic terminal regions commonly occur with alcohol use disorder (AUD). As pathological drug-seeking behavior may arise as a consequence of alcohol-induced neuroadaptations, it is critical to understand how such changes increase the likelihood of relapse. This report examined resting-state functional connectivity (RSFC) using both a seed-based and model-free approach in individuals in treatment for AUD and how dysregulation of network connectivity contributes to treatment outcomes. In order to provide a mechanism by which neural networks promote relapse, interactive effects of mesocorticolimbic connectivity and AUD risk factors in treatment completers and non-completers were examined. AUD group showed stronger RSFC between striatum, insula, and anterior cingulate cortex than controls. Within the AUD group, non-completers compared to completers showed enhanced RSFC between (1) striatum-insula, (2) executive control network (ECN)-amygdala, and (3) basal ganglia/salience network and striatum, precuneus, and insula. Completers showed enhanced RSFC between striatum-right dorsolateral prefrontal cortex. Furthermore, completers and non-completers differed in relationships between RSFC and relapse risk factors, where non-completers exhibited positive associations between craving intensity and RSFC of striatum-insula and ECN-amygdala. These findings provide evidence for interactions between corticolimbic connectivity in AUD and craving and establish an important link between network connectivity and dynamic risk factors that contribute to relapse. Results demonstrate that relapse vulnerability is attributed to craving dysregulation manifested by enhanced connectivity in striato-limbic regions and diminished corticostriatal connectivity.
Collapse
Affiliation(s)
- Milky Kohno
- Department of Psychiatry, Oregon Health & Science University, Portland, OR, United States.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States.,Methamphetamine Abuse Research Center, Portland, OR, United States
| | - Laura E Dennis
- Department of Psychiatry, Oregon Health & Science University, Portland, OR, United States.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States.,Methamphetamine Abuse Research Center, Portland, OR, United States
| | - Holly McCready
- Department of Psychiatry, Oregon Health & Science University, Portland, OR, United States.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States.,Methamphetamine Abuse Research Center, Portland, OR, United States
| | - William F Hoffman
- Department of Psychiatry, Oregon Health & Science University, Portland, OR, United States.,Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States.,Methamphetamine Abuse Research Center, Portland, OR, United States.,Mental Health and Clinical Neurosciences Division, Portland, OR, United States.,Research Service Veterans Affairs Portland Healthcare System, Portland, OR, United States
| |
Collapse
|
25
|
Affiliation(s)
- M. Chono
- Asahi Chemical Industry Co., Ltd. Kojima-Shionasu, Kurashiki-City Okayama, Japan 711
| | - S. Fukuoka
- Asahi Chemical Industry Co., Ltd. Kojima-Shionasu, Kurashiki-City Okayama, Japan 711
| | - M. Kohno
- Asahi Chemical Industry Co., Ltd. Kojima-Shionasu, Kurashiki-City Okayama, Japan 711
| |
Collapse
|
26
|
Takagi K, Kanemitsu H, Tomukai N, Oka H, Tamura A, Kohno M, Mitsuda K, Yoshida S, Sano K. Changes of superoxide dismutase activity and ascorbic acid in focal cerebral ischaemia in rats. Neurol Res 2016; 14:26-30. [PMID: 1351255 DOI: 10.1080/01616412.1992.11740006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Free radical reactions are supposed to cause ischaemic brain damage, and active oxygens can initiate these chains reaction. If active oxygens play important roles in ischaemic brain damage, the activity of superoxide dismutase, scavenger of superoxide anion, is supposed to decrease in ischaemic brain. The reduced form of ascorbic acid also scavenges superoxide anion. In rat middle cerebral artery focal ischaemia, we investigated the changes in superoxide dismutase activity and the concentration of reduced ascorbate up to 48 hours. Middle cerebral artery territory of each cerebral hemisphere was homogenized. The supernatant was divided into two aliquots; one was dialysed to remove ascorbate and the other was not. The enzyme activity of the dialysed specimen from the ischaemic hemisphere did not decrease within 4 h after the arterial occlusion. The activity of the dialysed specimen from the nonischaemic side remained unchanged during the examination. Reduced ascorbate levels in nondialysed samples showed similar changes to the superoxide dismutase activities in the dialysed samples. Our data suggest that ascorbic acid may exert the enzyme activity and that the enzyme activity remains at the normal level in the early phase of ischaemia despite the irreversible ischaemic changes that take place within 4 h after the onset of ischaemia.
Collapse
Affiliation(s)
- K Takagi
- Department of Neurosurgery, University Hospital, Teikyo University School of Medicine, Kawasaki-shi, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Kukida Y, Kasahara A, Seno T, Inoue T, Kamio N, Sagawa R, Kida T, Nakabayashi A, Nagahara H, Yamamoto A, Morita S, Ito H, Kohno M, Kawahito Y. AB0256 Very Early Response To Abatacept Could Be A Predictive Factor for Repair of Bone Erosion in Patients with Rheumatoid Arthritis Assessed by MRI. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.4018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
28
|
Seno T, Nonaka D, Kohno M, Sofue H, Kasahara A, Sagawa R, Kida T, Kukida Y, Fujioka K, Fujii W, Murakami K, Lee LJ, Tanaka K, Kawahito Y. AB0247 A New Disease Activity Biomarker Alternative To CRP under Tocilizumab Therapy for Rheumatoid Arthritis via Peptidomic Analysis. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
29
|
Kohno M, Nurmi EL, Laughlin CP, Morales AM, Gail EH, Hellemann GS, London ED. Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making. Neuropsychopharmacology 2016; 41:695-703. [PMID: 26119471 PMCID: PMC4707816 DOI: 10.1038/npp.2015.192] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/09/2015] [Revised: 06/02/2015] [Accepted: 06/03/2015] [Indexed: 01/08/2023]
Abstract
Brain imaging has revealed links between prefrontal activity during risky decision-making and striatal dopamine receptors. Specifically, striatal dopamine D2-like receptor availability is correlated with risk-taking behavior and sensitivity of prefrontal activation to risk in the Balloon Analogue Risk Task (BART). The extent to which these associations, involving a single neurochemical measure, reflect more general effects of dopaminergic functioning on risky decision making, however, is unknown. Here, 65 healthy participants provided genotypes and performed the BART during functional magnetic resonance imaging. For each participant, dopamine function was assessed using a gene composite score combining known functional variation across five genes involved in dopaminergic signaling: DRD2, DRD3, DRD4, DAT1, and COMT. The gene composite score was negatively related to dorsolateral prefrontal cortical function during risky decision making, and nonlinearly related to earnings on the task. Iterative permutations of all possible allelic variations (7777 allelic combinations) was tested on brain function in an independently defined region of the prefrontal cortex and confirmed empirical validity of the composite score, which yielded stronger association than 95% of all other possible combinations. The gene composite score also accounted for a greater proportion of variability in neural and behavioral measures than the independent effects of each gene variant, indicating that the combined effects of functional dopamine pathway genes can provide a robust assessment, presumably reflecting the cumulative and potentially interactive effects on brain function. Our findings support the view that the links between dopaminergic signaling, prefrontal function, and decision making vary as a function of dopamine signaling capacity.
Collapse
Affiliation(s)
- Milky Kohno
- Department of Psychiatry and Biobehavioral Sciences and Semel Institute, University of California Los Angeles, Los Angeles, CA, USA
| | - Erika L Nurmi
- Department of Psychiatry and Biobehavioral Sciences and Semel Institute, University of California Los Angeles, Los Angeles, CA, USA
| | - Christopher P Laughlin
- Department of Psychiatry and Biobehavioral Sciences and Semel Institute, University of California Los Angeles, Los Angeles, CA, USA
| | - Angelica M Morales
- Department of Psychiatry and Biobehavioral Sciences and Semel Institute, University of California Los Angeles, Los Angeles, CA, USA
| | - Emma H Gail
- Department of Psychiatry and Biobehavioral Sciences and Semel Institute, University of California Los Angeles, Los Angeles, CA, USA
| | - Gerhard S Hellemann
- Department of Psychiatry and Biobehavioral Sciences and Semel Institute, University of California Los Angeles, Los Angeles, CA, USA
| | - Edythe D London
- Department of Psychiatry and Biobehavioral Sciences and Semel Institute, University of California Los Angeles, Los Angeles, CA, USA,Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA,Brain Research Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA,Semel Institute of Neuroscience and Human Behavior, University of California Los Angeles, 760 Westwood Plaza, Los Angeles, CA 90024-1759, USA, Tel: +310 825 0606, Fax: +310 825 0812, E-mail:
| |
Collapse
|
30
|
Yagi M, Kohno M, Asagiri K, Ikeda T, Okada T, Kanada S, Kawashima S, Goto Y, Takano S, Yasufuku M, Wada M. Twenty-year trends in neonatal surgery based on a nationwide Japanese surveillance program. Pediatr Surg Int 2015; 31:955-62. [PMID: 26319695 DOI: 10.1007/s00383-015-3775-z] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 08/06/2015] [Indexed: 10/23/2022]
Abstract
AIM To discuss the chronological changes observed in a national survey of neonatal surgery in Japan performed every 5 years by the Committee in the Japanese Society of Pediatric Surgeons. METHODS We analyzed the data obtained for 20 years from 1993 to 2013 and herein report the chronological changes. RESULTS The number of summarized cases was least in 1993, with 2806 cases, and subsequently increased to 3753 cases in 2013. The mortality rate among the patients with maternal transport linearly decreased (p = 0.0386). Although the proportion of extremely low birth weight infants linearly increased (p = 0.0014), with an annual rate of +0.39 %, the mortality rate linearly decreased (p = 0.0010), with an annual rate of -1.68 %. Moreover, the overall mortality rate linearly decreased (p = 0.0002), with an annual rate of -0.26 %. Most diseases were observed to exhibit a decline in the mortality rate with the same trend as overall mortality. The decline in the mortality rate was most robust with respect to congenital diaphragmatic hernia (CDH). The mortality rates, except for that of CDH, omphalocele, esophageal atresia, and intestinal perforation, declined to 5 % or lower by 2013. CONCLUSIONS The present findings may be the result of remarkable progress in perinatal management.
Collapse
Affiliation(s)
- M Yagi
- Committee of Academic Survey and Advanced Medical Science, Japanese Society of Pediatric Surgeons, Tokyo, Japan. .,Department of Pediatric Surgery, Kurume University School of Medicine, 67 Asahimachi, Kururme-City, Fukuoka, 830-0011, Japan.
| | - M Kohno
- Committee of Academic Survey and Advanced Medical Science, Japanese Society of Pediatric Surgeons, Tokyo, Japan
| | - K Asagiri
- Committee of Academic Survey and Advanced Medical Science, Japanese Society of Pediatric Surgeons, Tokyo, Japan
| | - T Ikeda
- Committee of Academic Survey and Advanced Medical Science, Japanese Society of Pediatric Surgeons, Tokyo, Japan
| | - T Okada
- Committee of Academic Survey and Advanced Medical Science, Japanese Society of Pediatric Surgeons, Tokyo, Japan
| | - S Kanada
- Committee of Academic Survey and Advanced Medical Science, Japanese Society of Pediatric Surgeons, Tokyo, Japan
| | - S Kawashima
- Committee of Academic Survey and Advanced Medical Science, Japanese Society of Pediatric Surgeons, Tokyo, Japan
| | - Y Goto
- Committee of Academic Survey and Advanced Medical Science, Japanese Society of Pediatric Surgeons, Tokyo, Japan
| | - S Takano
- Committee of Academic Survey and Advanced Medical Science, Japanese Society of Pediatric Surgeons, Tokyo, Japan
| | - M Yasufuku
- Committee of Academic Survey and Advanced Medical Science, Japanese Society of Pediatric Surgeons, Tokyo, Japan
| | - M Wada
- Committee of Academic Survey and Advanced Medical Science, Japanese Society of Pediatric Surgeons, Tokyo, Japan
| |
Collapse
|
31
|
Morales AA, Kohno M, Robertson CL, Dean AC, Mandelkern MA, London ED. Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users. Mol Psychiatry 2015; 20:764-71. [PMID: 25896164 PMCID: PMC4440838 DOI: 10.1038/mp.2015.47] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/15/2014] [Revised: 02/19/2015] [Accepted: 02/24/2015] [Indexed: 02/05/2023]
Abstract
Dysfunction of the mesocorticolimbic system has a critical role in clinical features of addiction. Despite evidence suggesting that midbrain dopamine receptors influence amphetamine-induced dopamine release and that dopamine is involved in methamphetamine-induced neurotoxicity, associations between dopamine receptors and gray-matter volume have been unexplored in methamphetamine users. Here we used magnetic resonance imaging and [(18)F]fallypride positron emission tomography, respectively, to measure gray-matter volume (in 58 methamphetamine users) and dopamine D2/D3 receptor availability (binding potential relative to nondisplaceable uptake of the radiotracer, BPnd) (in 31 methamphetamine users and 37 control participants). Relationships between these measures and self-reported drug craving were examined. Although no difference in midbrain D2/D3 BPnd was detected between methamphetamine and control groups, midbrain D2/D3 BPnd was positively correlated with gray-matter volume in the striatum, prefrontal cortex, insula, hippocampus and temporal cortex in methamphetamine users, but not in control participants (group-by-midbrain D2/D3 BPnd interaction, P<0.05 corrected for multiple comparisons). Craving for methamphetamine was negatively associated with gray-matter volume in the insula, prefrontal cortex, amygdala, temporal cortex, occipital cortex, cerebellum and thalamus (P<0.05 corrected for multiple comparisons). A relationship between midbrain D2/D3 BPnd and methamphetamine craving was not detected. Lower midbrain D2/D3 BPnd may increase vulnerability to deficits in gray-matter volume in mesocorticolimbic circuitry in methamphetamine users, possibly reflecting greater dopamine-induced toxicity. Identifying factors that influence prefrontal and limbic volume, such as midbrain BPnd, may be important for understanding the basis of drug craving, a key factor in the maintenance of substance-use disorders.
Collapse
Affiliation(s)
- Angelica A. Morales
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA
| | - Milky Kohno
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA
| | - Chelsea L. Robertson
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA,Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA
| | - Andy C. Dean
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA,Brain Research Institute, University of California, Los Angeles, Los Angeles, CA
| | - Mark A. Mandelkern
- Department of Physics, University of California Irvine, Irvine, CA,Veterans Administration of Greater Los Angeles Health System, Los Angeles CA
| | - Edythe D. London
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA,Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA,Brain Research Institute, University of California, Los Angeles, Los Angeles, CA,Veterans Administration of Greater Los Angeles Health System, Los Angeles CA
| |
Collapse
|
32
|
Dean AC, Kohno M, Morales AM, Ghahremani DG, London ED. Denial in methamphetamine users: Associations with cognition and functional connectivity in brain. Drug Alcohol Depend 2015; 151:84-91. [PMID: 25840750 PMCID: PMC4447566 DOI: 10.1016/j.drugalcdep.2015.03.004] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/05/2014] [Revised: 02/18/2015] [Accepted: 03/04/2015] [Indexed: 10/23/2022]
Abstract
BACKGROUND Despite harmful consequences of drug addiction, it is common for individuals with substance use disorders to deny having problems with drugs. Emerging evidence suggests that some drug users lack insight into their behavior due to neurocognitive dysfunction, but little research has examined potential neurocognitive contributions to denial. METHODS This study explored the relationship between denial, cognitive performance and functional connectivity in brain. The participants were 58 non-treatment-seeking, methamphetamine-dependent participants who completed the URICA precontemplation scale, a self-report measure of denial of drug problems warranting change, as well as a cognitive test battery. A subset of participants (N = 21) had functional MRI scans assessing resting-state functional connectivity. Given literature indicating roles of the rostral anterior cingulate (rACC), anterior insula and precuneus in self-awareness, relationships between denial and resting-state connectivity were tested using seeds placed in these regions. RESULTS The results revealed a negative relationship between denial and an overall cognitive battery score (p = 0.001), the effect being driven particularly by performance on tests of memory and executive function. Denial was negatively associated with strength of connectivity between the rACC and regions of the frontal lobe (precentral gyri, left ventromedial prefrontal cortex, left orbitofrontal cortex), limbic system (left amygdala, left hippocampus and left parahippocampal gyrus), occipital lobes and cerebellum; and between the precuneus and the midbrain and cerebellum. Anterior insula connectivity was unrelated to denial. CONCLUSIONS These findings suggest that denial by methamphetamine users is linked with a cognitive and neural phenotype that may impede the development of insight into their behavior.
Collapse
Affiliation(s)
- Andy C. Dean
- Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA,Brain Research Institute, David Geffen School of Medicine, Los Angeles, CA, 90024, USA,Corresponding author: Andy C. Dean (), UCLA Semel Institute for Neuroscience and Human Behavior, 760 Westwood Plaza, Los Angeles, CA, United States of America 90095-1759, Tel: +1 310 825 5839; fax: +1 310 825 0812
| | - Milky Kohno
- Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA
| | - Angelica M. Morales
- Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA
| | - Dara G. Ghahremani
- Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA
| | - Edythe D. London
- Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, 90024, USA,Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, Los Angeles, CA, 90024 USA,Brain Research Institute, David Geffen School of Medicine, Los Angeles, CA, 90024, USA
| |
Collapse
|
33
|
Seno T, Yamamoto A, Kukida Y, Tominaga A, Kida T, Nakabayashi A, Fujioka K, Nagahara H, Murakami K, Fujii W, Oda R, Kubo T, Kohno M, Kawahito Y. AB0910 Once-Weekly Teriparatide is Effective for Glucocorticoid-Induced Osteoporosis Patients with Collagen Diseases. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.3667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
34
|
London ED, Kohno M, Morales AM, Ballard ME. Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Res 2014; 1628:174-85. [PMID: 25451127 DOI: 10.1016/j.brainres.2014.10.044] [Citation(s) in RCA: 119] [Impact Index Per Article: 11.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2014] [Revised: 10/17/2014] [Accepted: 10/22/2014] [Indexed: 01/05/2023]
Abstract
Despite aggressive efforts to contain it, methamphetamine use disorder continues to be major public health problem; and with generic behavioral therapies still the mainstay of treatment for methamphetamine abuse, rates of attrition and relapse remain high. This review summarizes the findings of structural, molecular, and functional neuroimaging studies of methamphetamine abusers, focusing on cortical and striatal abnormalities and their potential contributions to cognitive and behavioral phenotypes that can serve to promote compulsive drug use. These studies indicate that individuals with a history of chronic methamphetamine abuse often display several signs of corticostriatal dysfunction, including abnormal gray- and white-matter integrity, monoamine neurotransmitter system deficiencies, neuroinflammation, poor neuronal integrity, and aberrant patterns of brain connectivity and function, both when engaged in cognitive tasks and at rest. More importantly, many of these neural abnormalities were found to be linked with certain addiction-related phenotypes that may influence treatment response (e.g., poor self-control, cognitive inflexibility, maladaptive decision-making), raising the possibility that they may represent novel therapeutic targets.
Collapse
Affiliation(s)
- Edythe D London
- Departments of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90024; Departments of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California 90024; Departments of Brain Research Institute, University of California, Los Angeles, Los Angeles, California 90024.
| | - Milky Kohno
- Departments of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90024
| | - Angelica M Morales
- Departments of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90024
| | - Michael E Ballard
- Departments of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90024
| |
Collapse
|
35
|
Shiono S, Matsutani N, Okumura S, Nakajima J, Horio H, Kohno M, Ikeda N, Kawamura M. 032 * THE PROGNOSTIC IMPACT OF LYMPH NODE DISSECTION IN PULMONARY METASTASECTOMY. Interact Cardiovasc Thorac Surg 2014. [DOI: 10.1093/icvts/ivu276.32] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
36
|
Kou K, Okawa T, Yamaguchi Y, Ono J, Inoue Y, Kohno M, Matsukura S, Kambara T, Ohta S, Izuhara K, Aihara M. Periostin levels correlate with disease severity and chronicity in patients with atopic dermatitis. Br J Dermatol 2014; 171:283-91. [PMID: 24601864 DOI: 10.1111/bjd.12943] [Citation(s) in RCA: 71] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/26/2014] [Indexed: 12/14/2022]
Abstract
BACKGROUND Recent findings indicate that periostin, an extracellular matrix protein induced by T helper 2 cytokines, plays a critical role in the pathogenesis of atopic dermatitis (AD). OBJECTIVES To determine whether serum periostin level is associated with clinical phenotype in adult patients with AD. METHODS An enzyme-linked immunosorbent assay was performed to determine serum periostin levels in 257 adult patients with AD, 66 patients with psoriasis vulgaris (PV) as a disease control and 25 healthy controls. Serum periostin levels were analysed together with clinical characteristics and laboratory parameters, including thymus and activation-regulated chemokine (TARC), lactate dehydrogenase (LDH), blood eosinophil count and total IgE. Immunohistochemical analysis evaluated the expression of periostin in association with various clinical phenotypes of AD. The effect of treatment on serum periostin level was also assessed. RESULTS Serum periostin was significantly higher in patients with AD than in patients with PV and healthy controls. Periostin level was found to be positively correlated with disease severity, TARC level, LDH level and eosinophil count, but not with IgE level. Higher serum periostin level was observed in patients with extrinsic AD compared with patients with intrinsic AD; the positive correlation of disease severity disappeared in patients with intrinsic AD. Robust expression of periostin was detected in the dermis of patients with AD with erythroderma, lichenification and, to a lesser extent, scaly erythema. Serial measurement of serum periostin revealed decreased levels of periostin after treatment for AD. CONCLUSIONS Periostin may play a critical role in disease severity and chronicity in the pathogenesis of AD.
Collapse
Affiliation(s)
- K Kou
- Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Kohno M, Morales AM, Ghahremani DG, Hellemann G, London ED. Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence. JAMA Psychiatry 2014; 71:812-20. [PMID: 24850532 PMCID: PMC4119006 DOI: 10.1001/jamapsychiatry.2014.399] [Citation(s) in RCA: 119] [Impact Index Per Article: 11.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
IMPORTANCE Various neuropsychiatric disorders, especially addictions, feature impairments in risky decision making; clarifying the neural mechanisms underlying this problem can inform treatment. OBJECTIVE To determine how methamphetamine-dependent and control participants differ in brain activation during a risky decision-making task, resting-state functional connectivity within mesolimbic and executive control circuits, and the relationships between these measures. DESIGN, SETTING, AND PARTICIPANTS A case-control, functional magnetic resonance imaging study of methamphetamine-dependent and healthy comparison participants at rest and when performing the Balloon Analogue Risk Task, which involves the choice to pump a balloon or to cash out in the context of uncertain risk. Conducted at a clinical research center at an academic institution, this study involved 25 methamphetamine-dependent and 27 control participants. MAIN OUTCOMES AND MEASURES Parametric modulation of activation in the striatum and right dorsolateral prefrontal cortex (rDLPFC; ie, the degree to which activation changed as a linear function of risk and potential reward), both indexed by pump number, and resting-state functional connectivity, measured in the whole brain with seeds in the midbrain and rDLPFC. Relationships between these outcomes were also tested. RESULTS Parametric modulation of cortical and striatal activation by pump number during risk taking differed with group. It was stronger in the ventral striatum but weaker in the rDLPFC in methamphetamine-dependent participants than control individuals. Methamphetamine-dependent participants also exhibited greater resting-state functional connectivity of the midbrain with the putamen, amygdala, and hippocampus (P < .05, whole brain, cluster corrected). This connectivity was negatively related to modulation of rDLPFC activation by risk level during risky decision making. In control participants, parametric modulation of rDLPFC activation by risk during decision making was positively related to resting-state functional connectivity of the rDLPFC with the striatum. CONCLUSIONS AND RELEVANCE Maladaptive decision making by methamphetamine users may reflect circuit-level dysfunction, underlying deficits in task-based activation. Heightened resting-state connectivity within the mesocorticolimbic system, coupled with reduced prefrontal cortical connectivity, may create a bias toward reward-driven behavior over cognitive control in methamphetamine users. Interventions to improve this balance may enhance treatments for stimulant dependence and other disorders that involve maladaptive decision making.
Collapse
Affiliation(s)
- Milky Kohno
- Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA 90095
| | - Angelica M. Morales
- Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA 90095
| | - Dara G. Ghahremani
- Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA 90095
| | - Gerhard Hellemann
- Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA 90095
| | - Edythe D. London
- Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA 90095,Brain Research Institute, University of California Los Angeles, Los Angeles, CA 90095,Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA 90095
| |
Collapse
|
38
|
Morales AM, Ghahremani D, Kohno M, Hellemann GS, London ED. Cigarette exposure, dependence, and craving are related to insula thickness in young adult smokers. Neuropsychopharmacology 2014; 39:1816-22. [PMID: 24584328 PMCID: PMC4059909 DOI: 10.1038/npp.2014.48] [Citation(s) in RCA: 61] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/01/2013] [Revised: 01/07/2014] [Accepted: 02/21/2014] [Indexed: 12/12/2022]
Abstract
The age period spanning late adolescence to emergent adulthood is associated with the highest prevalence of cigarette smoking in the United States, and is also a time of continued brain development. Nonetheless, although prior research has shown group differences in brain structure associated with smoking status in adults, few studies have examined how smoking and associated behavioral states relate to brain structure in this age group. Neuroimaging and lesion studies have suggested that the insula, a cortical region that integrates heterogeneous signals about internal states and contributes to executive functions, plays an important role in cigarette smoking behavior. Using high-resolution structural magnetic resonance imaging, we therefore measured cortical thickness of the insula in 18 smokers and 24 nonsmokers between the ages of 16 and 21 years. There were no group differences in insula thickness, but cigarette exposure (pack-years) was negatively associated with thickness in right insula. Cigarette dependence and the urge to smoke were negatively related to cortical thickness in the right ventral anterior insula. Although the results do not demonstrate causation, they do suggest that there are effects of cigarette exposure on brain structure in young smokers, with a relatively short smoking history. It is possible that changes in the brain due to prolonged exposure or to the progression of dependence lead to more extensive structural changes, manifested in the reported group differences between adult smokers and nonsmokers. Structural integrity of the insula may have implications for predicting long-term cigarette smoking and problems with other substance abuse in this population.
Collapse
Affiliation(s)
- Angelica M Morales
- Neuroscience Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA, USA,Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA,Brain Research Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | - Dara Ghahremani
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA
| | - Milky Kohno
- Neuroscience Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA, USA,Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA,Brain Research Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | - Gerhard S Hellemann
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA
| | - Edythe D London
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA,Brain Research Institute, University of California, Los Angeles, Los Angeles, CA, USA,Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA,Semel Institute of Neuroscience and Human Behavior, University of California, Los Angeles, 760 Westwood Plaza, Los Angeles, CA 90024-1759, USA, Tel: +1 310 825 0606, Fax: +1 310 825 0812, E-mail:
| |
Collapse
|
39
|
Abstract
Complementary DNA encoding Rhizopus niveus lipase (RNL) was isolated from the R. niveus IF04759 cDNA library using a synthetic oligonucleotide corresponding to the amino acid sequence of the enzyme. A clone, which had an insert of 1.0 kilobase pairs, was found to contain the coding region of the enzyme. The lipase gene was expressed in Escherichia coli as a lacZ fusion protein. The mature RNL consisted of 297 amino acid residues with a molecular mass of 32 kDa. The RNL sequence showed significant overall homology to Rhizomucor miehei lipase and the putative active site residues were strictly conserved.
Collapse
Affiliation(s)
- W Kugimiya
- Central Research Institute, Fuji Oil Co., Ltd., Ibaraki, Japan
| | | | | | | |
Collapse
|
40
|
Fujii W, Ashihara E, Nagahara H, Kukida Y, Ishigaki R, Kasahara A, Sagawa T, Seno T, Yamamoto A, Kohno M, Oda R, Tokunaga D, Kubo T, Kawahito Y. OP0175 Monocarboxylate Transporter (MCT)-4, Associated with the Decrease of Synovial Fluid Ph, is A Novel Therapeutic Target of Rheumatoid Arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
41
|
Kukida Y, Kida T, Inoue T, Isoda Y, Sagawa T, Ishigaki R, Kasahara A, Nakabayashi A, Fujioka K, Nagahara H, Fujii W, Murakami K, Seno T, Yamamoto A, Kohno M, Kawahito Y. AB0501 Retrospective Study of Multitarget Therapy with Combination of Mizoribine and Tacrolimus for Systemic Lupus Erythematosus with or without Nephritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.3186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
42
|
Fujioka K, Kishida T, Kukida Y, Nagahara H, Fujii W, Murakami K, Seno T, Yamamoto A, Kohno M, Mazda O, Kawahito Y. SAT0562 Directly Reprogrammed Osteoblasts Genetically Engineered to Produce Interleukin-10 Significantly Suppress Osteoclastgenesis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
43
|
Nishioka S, Sofue T, Inui M, Nishijima Y, Moriwaki K, Hara T, Mashiba T, Kakehi Y, Kohno M. Mineral and Bone Disorder Is Temporary in Patients Treated With Early Rapid Corticosteroid Reduction After Kidney Transplantation: A Single-Center Experience. Transplant Proc 2014; 46:514-20. [DOI: 10.1016/j.transproceed.2013.11.153] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2013] [Revised: 10/25/2013] [Accepted: 11/27/2013] [Indexed: 12/12/2022]
|
44
|
Fujii W, Ashihara E, Hirai H, Nagahara H, Fujioka K, Murakami K, Seno T, Yamamoto A, Ishino H, Kohno M, Maekawa T, Kawahito Y. THU0112 Myeloid-Derived Suppressor Cells have Regulatory Roles in Mouse Collagen-Induced Arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.640] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
45
|
Miyazaki S, Yoshikawa T, Hashiramoto A, Yamada R, Tsubouchi Y, Kohno M, Kawahito Y, Kondo M, Sano H. ACTH expression in synovium of patients with rheumatoid arthritis and Lewis rats with adjuvant arthritis. Mod Rheumatol 2014; 12:206-12. [PMID: 24387059 DOI: 10.3109/s101650200036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract Adrenocorticotropic hormone (ACTH) and another pro-opiomelanocortin-derived neuropeptide, β-endorphin (β-End), are stimulated by corticotropin-releasing hormone (CRH) at the anterior pituitary. CRH and β-End have predominantly proinflammatory effects in peripheral inflammatory sites. We have supposed that inflammatory stimuli develop ACTH as well as β-End. In this study, we investigated the expression of ACTH in inflamed synovial tissue from patients with rheumatoid arthritis (RA) and osteoarthritis (OA), and at inflammatory joints with adjuvant-induced arthritis (AA) in female Lewis (LEW/N) rats. The expression of ACTH immunostaining was significantly greater in synovium of RA patients than in that of OA patients (P < 0.0001), and correlated with the extent of inflammatory mononuclear cell infiltration. Extensive and intense intracellular ACTH immunostaining, which correlated with the advance in arthritis score, was observed in the synovial lining layer, inflammatory mononuclear cells, and fibroblast-like cells of synovium and chondrocytes in LEW/N rats with AA. In addition, we performed double immunostaining of the same sections from arthritic joints in rats with anti-ACTH and anti-CRH antibodies. ACTH and CRH colocalized in inflammatory mononuclear cells and fibroblast-like cells. ACTH may play a role in the pathogenesis of RA as well as CRH.
Collapse
Affiliation(s)
- S Miyazaki
- First Department of Internal Medicine, Kyoto Prefectural University of Medicine , 465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566 , Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Bohgaki T, Notoya A, Mukai M, Kohno M. Thrombotic thrombocytopenic purpura in a patient with rapidly progressive scleroderma. Mod Rheumatol 2014; 10:256-9. [DOI: 10.3109/s101650070012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
47
|
Bohgaki M, Mukai M, Notoya A, Kohno M, Takada A. Vasculitis following implantation of a ventriculoperitoneal shunt tube made of silicone. Mod Rheumatol 2014; 13:73-5. [DOI: 10.3109/s101650300011] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
48
|
Kageji T, Oka H, Obata F, Tani K, Bando H, Tabata R, Kohno M. New support system using a mobile device for diagnostic image display and treatment of acute stroke in Japanese depopulated areas. Crit Care 2014. [PMCID: PMC4069488 DOI: 10.1186/cc13644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
49
|
Dean AC, Kohno M, Hellemann G, London ED. Childhood maltreatment and amygdala connectivity in methamphetamine dependence: a pilot study. Brain Behav 2014; 4:867-76. [PMID: 25365801 PMCID: PMC4178299 DOI: 10.1002/brb3.289] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/29/2014] [Revised: 09/02/2014] [Accepted: 09/05/2014] [Indexed: 11/15/2022] Open
Abstract
INTRODUCTION Childhood maltreatment, a well-known risk factor for the development of substance abuse disorders, is associated with functional and structural abnormalities in the adult brain, particularly in the limbic system. However, almost no research has examined the relationship between childhood maltreatment and brain function in individuals with drug abuse disorders. METHODS We conducted a pilot study of the relationship between childhood maltreatment (evaluated with the Childhood Trauma Questionnaire; Bernstein and Fink 1998) and resting-state functional connectivity of the amygdala (bilateral region of interest) with functional magnetic resonance imaging in 15 abstinent, methamphetamine-dependent research participants. Within regions that showed connectivity with the amygdala as a function of maltreatment, we also evaluated whether amygdala connectivity was associated positively with negative affect and negatively with healthy emotional processing. RESULTS The results indicated that childhood maltreatment was positively associated with resting-state connectivity between the amygdala and right hippocampus, right parahippocampal gyrus, right inferior temporal gyrus, right orbitofrontal cortex, cerebellum, and brainstem. Furthermore, connectivity between the amygdala and hippocampus was positively related to measures of depression, trait anxiety, and emotion dysregulation, and negatively related to self-compassion and dispositional mindfulness. CONCLUSIONS These findings suggest that childhood maltreatment may contribute to increased limbic connectivity and maladaptive emotional processing in methamphetamine-dependent adults, and that healthy emotion regulation strategies may serve as a therapeutic target to ameliorate the associated behavioral phenotype. Childhood maltreatment warrants further investigation as a potentially important etiological factor in the neurobiology and treatment of substance use disorders.
Collapse
Affiliation(s)
- Andy C Dean
- Department of Psychiatry and Biobehavioral Sciences and Semel Institute, David Geffen School of Medicine, University of California Los Angeles 760 Westwood Plaza, 90024, Los Angeles, California, USA ; Brain Research Institute, University of California Los Angeles Los Angeles, California, 90095, USA
| | - Milky Kohno
- Department of Psychiatry and Biobehavioral Sciences and Semel Institute, David Geffen School of Medicine, University of California Los Angeles 760 Westwood Plaza, 90024, Los Angeles, California, USA
| | - Gerhard Hellemann
- Department of Psychiatry and Biobehavioral Sciences and Semel Institute, David Geffen School of Medicine, University of California Los Angeles 760 Westwood Plaza, 90024, Los Angeles, California, USA
| | - Edythe D London
- Department of Psychiatry and Biobehavioral Sciences and Semel Institute, David Geffen School of Medicine, University of California Los Angeles 760 Westwood Plaza, 90024, Los Angeles, California, USA ; Brain Research Institute, University of California Los Angeles Los Angeles, California, 90095, USA ; Department of Molecular and Medical Pharmacology, University of California Los Angeles Los Angeles, California, 90095, USA
| |
Collapse
|
50
|
Kohno M, Ghahremani DG, Morales AM, Robertson CL, Ishibashi K, Morgan AT, Mandelkern MA, London ED. Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity. Cereb Cortex 2013; 25:236-45. [PMID: 23966584 DOI: 10.1093/cercor/bht218] [Citation(s) in RCA: 78] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
Decision-making involves frontolimbic and dopaminergic brain regions, but how prior choice outcomes, dopamine neurotransmission, and frontostriatal activity are integrated to affect choices is unclear. We tested 60 healthy volunteers using the Balloon Analogue Risk Task (BART) during functional magnetic resonance imaging. In the BART, participants can pump virtual balloons to increase potential monetary reward or cash out to receive accumulated reward; each pump presents greater risk and potential reward (represented by the pump number). In a separate session, we measured striatal D2/D3 dopamine receptor binding potential (BPND) with positron emission tomography in 13 of the participants. Losses were followed by fewer risky choices than wins; and during risk-taking after loss, amygdala and hippocampal activation exhibited greater modulation by pump number than after a cash-out event. Striatal D2/D3 BPND was positively related to the modulation of ventral striatal activation when participants decided to cash out and negatively to the number of pumps in the subsequent trial; but negatively related to the modulation of prefrontal cortical activation by pump number when participants took risk, and to overall earnings. These findings provide in vivo evidence for a potential mechanism by which dopaminergic neurotransmission may modulate risk-taking behavior through an interactive system of frontal and striatal activity.
Collapse
Affiliation(s)
- Milky Kohno
- Department of Psychiatry and Biobehavioral Sciences Neuroscience Interdepartmental Program
| | | | - Angelica M Morales
- Department of Psychiatry and Biobehavioral Sciences Neuroscience Interdepartmental Program
| | - Chelsea L Robertson
- Department of Molecular and Medical Pharmacology Veterans Administration of Greater Los Angeles Healthcare System
| | - Kenji Ishibashi
- Department of Psychiatry and Biobehavioral Sciences Veterans Administration of Greater Los Angeles Healthcare System
| | - Andrew T Morgan
- Department of Psychiatry and Biobehavioral Sciences Veterans Administration of Greater Los Angeles Healthcare System
| | - Mark A Mandelkern
- Veterans Administration of Greater Los Angeles Healthcare System Department of Physics, University of California Irvine, Irvine, CA, USA
| | - Edythe D London
- Department of Psychiatry and Biobehavioral Sciences Neuroscience Interdepartmental Program Department of Molecular and Medical Pharmacology Brain Research Institute, University of California Los Angeles University of California Los Angeles Semel Institute, Los Angeles, CA 90024, USA and Veterans Administration of Greater Los Angeles Healthcare System
| |
Collapse
|